Publications

Read the mathematics yourself.

Everything DeepSensi™ claims in public is written down, referenced, and offered for attack.

Patent-pendingPublished as proof and standard, not as a technical blueprint.

Formal Reliability Analysis of Multi-Layer Deterministic Verification in Clinical AI

WP-001 · Reliability engineering. The safety case: 23 barriers per IEC 61025, worst-case bound 3.23 × 10⁻⁶, empirical NEJM CPC validation (N=301), and the Gomola Framework.

The Flawed Yardstick: Why Static Medical Benchmarks Penalize Clinical Safety

WP-002 · Evaluation science. The Safe Triage Paradox, documented benchmark defects, and Auto-CSA validated on N=301.

The Hyper Consilium: Human Clinicians as Scored Nodes in a Fractal AI Diagnostic Swarm

WP-003 · Diagnostic architecture. specialist agents for every discipline, dual-pathway reasoning, a unified reputation economy, and outcome-gated physician royalties.

The Global Clinical Performance Score

WP-004 · Reputation science. An objective, bias-resistant, anti-gaming framework for physician reputation.

Autonomous Bayesian Hypothesis Generation and Adversarial Validation

WP-005 · Autonomous research. The AutoResearcher-HYPO architecture, anchored in deterministic biological-network validation.

Golden Horizon: AI-Mediated Compassionate Access

WP-006 · Compassionate access. Autonomous, borderless matching of patients to experimental therapies, free by architectural mandate.

GERN: Privacy-Preserving Syndromic Surveillance from Ambient Clinical Documentation

WP-007 · Digital epidemiology. Credible early warning as a privacy-preserving by-product of clinical care.

The Gomola Framework: A Quantitative Safety Certification Standard for Clinical AI

DSS-001 · Standard definition. Four certification levels, five auditable pillars, vendor-neutral and royalty-free.

A Quantitative Safety Standard for Clinical AI: The DeepSensi™ Standard

Perspective. The case for graded, quantitative reliability targets in clinical AI.

Cohort: N=301 NEJM CPC cases (2014 to 2023), development-cohort; a confirmatory study is designated. We publish the proof, the standard, and the audit. We do not publish the blueprint.